NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Latest Information Update: 25 Apr 2025
At a glance
- Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 20 Mar 2025 Planned End Date changed from 20 Mar 2025 to 18 Mar 2026.
- 21 Mar 2024 Planned End Date changed from 1 Mar 2025 to 20 Mar 2025.
- 05 Mar 2024 Planned End Date changed from 1 Mar 2024 to 1 Mar 2025.